Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs
2007

Effects of Nicotine on Anxiety and Depression in Mice

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): Hayase Tamaki

Primary Institution: Department of Legal Medicine, Kyoto University

Hypothesis

The study investigates the time course of anxiety- and depression-related behavioral alterations induced by nicotine and the effects of anxiolytic and cannabinoid drugs.

Conclusion

The study found that nicotine induces overlapping anxiety- and depression-related symptoms in mice, which can be influenced by certain drugs.

Supporting Evidence

  • Repeated nicotine treatments caused prolonged anxiety and depression symptoms in mice.
  • The serotonin 1A antagonist WAY 100135 and the cannabinoid virodhamine showed strong effects against anxiety symptoms.
  • Virodhamine was effective against depression symptoms in both single and repeated treatment groups.

Takeaway

Nicotine can make mice feel anxious and sad, and some medicines can help them feel better.

Methodology

Mice were treated with nicotine and tested for anxiety and depression using the elevated plus-maze and forced swimming tests.

Limitations

The study was conducted on mice, which may not fully represent human responses to nicotine.

Participant Demographics

Male ICR mice, aged 60-90 days.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2202-8-76

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication